ubmslateDI-logo-ubm

DI Mobile Menu

Search form

Topics:

Nadim Michel Daher

Nadim Michel Daher

Principal Analyst Medical Imaging, Frost & Sullivan

Posts by Author

Recent FDA review process of inconclusive clinical studies creates a potentially unhealthy decision-making environment for patients needing gadolinium-enhanced MRIs.

The beauty of medical imaging is easy to overlook, but it's still there.

Major Vendors Seek Early-Mover Advantage in Operationalizing Advanced Cloud-Based Imaging Informatics Platforms

Big ticket deals for prospective investors on the RSNA 2016 showfloor.

RSNA 2016 displays more signs pointing towards the blending of diagnostic, interventional, and therapeutic imaging.

The focus of the big three vendors at RSNA 2016.

Latest developments in cardiac PET radiopharmaceuticals from ASNC 2016.

American Society of Nuclear Cardiology 2016 shows the cardiac PET value chain still faces more headwinds than tailwinds.

SIIM16 helped uncover significant baby steps towards outcomes-based purchasing.

SIIM 2016 provides a reality check on the deconstructed deployment model for PACS

Pages

By clicking Accept, you agree to become a member of the UBM Medica Community.